retatrutide nonalcoholic fatty liver disease nash trial Recent guidelines for Non-Alcoholic (NAFLD)/ Fatty Liver Disease (FLD): Are they already outdated and in need of supplementation? Researchers are reporting promising results – Fatty Liver Disease Clinical Trials

That said, risk tolerance has broadened significantly

Also read: Science-Based Hydration Strategies for Better Living & Performance You Didnt Know (05/05/25) Longevity community couldnt resist GLP1s Given our newsletters core focus is on longevity itself, we couldnt help but give the perspective of the longevity community on GLP-1s and other WLMs

The surge of interest largely comes from popular GLP-1 drugs used for diabetes and GLP-1 weight loss treatments

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Senile Osteoporosis Senile osteoporosis is primary osteoporosis, and its main characteristics are changes in bone microstructure, decreased bone density, and decreased bone strength

By suppressing hunger, this process offers multiple benefits, including the inhibition of sugar production in the liver, reduction of blood sugar levels, promotion of anti-inflammatory activity, and enhancement of cardiovascular health

The research is here, but insurance coverage hasnt caught up